PRESS RELEASE published on 05/16/2025 at 18:30, 11 months 26 days ago Information relative au nombre total de droits de vote et d'actions composant le capital social Néovacs communique le nombre d'actions et de droits de vote composant son capital social conformément aux régulations. La société développe des thérapies pour des maladies inflammatoires et auto-immunes Droits De Vote Capital Social Biopharmaceutique Néovacs Thérapies
BRIEF published on 05/06/2025 at 20:05, 1 year ago Capital reduction at Neovacs Capital Reduction Investor Caution Dilutive Financing Nominal Value Stock Market Pressure
BRIEF published on 05/06/2025 at 20:05, 1 year ago Réduction du capital chez Néovacs Valeur Nominale Réduction Capital Financements Dilutifs Pression Boursière Prudence Investisseur
PRESS RELEASE published on 05/06/2025 at 20:00, 1 year ago Ajustement de la valeur nominale Réduction de capital pour Néovacs, société biopharmaceutique, suite à résolution votée en AG. Focus sur thérapies pour maladies inflammatoires et auto-immunes Biopharmaceutique Réduction De Capital Maladies Inflammatoires Néovacs Thérapies
BRIEF published on 05/06/2025 at 08:05, 1 year ago Neovacs: 2024 Annual Results and Outlook Financial Results Funding MRNA Vaccine Pharnext Néovacs
BRIEF published on 05/06/2025 at 08:05, 1 year ago Néovacs : Résultats annuels 2024 et perspectives Résultats Financiers Financement Pharnext Néovacs Vaccin ARNm
PRESS RELEASE published on 05/06/2025 at 08:00, 1 year ago Résultats annuels 2024 Néovacs annonce des avancées dans le développement de vaccins ARNm contre les allergies, avec une valorisation par un cabinet indépendant. La société présente ses résultats annuels 2024 et son point sur le financement ainsi que le récentrage du portefeuille de participations et de l'investissement dans Pharnext Financement Résultats Annuels Néovacs Allergies Vaccin ARNm
BRIEF published on 05/05/2025 at 12:05, 1 year ago Néovacs réalise une levée de fonds de 1,2 million d'euros Investissement Biotechnologie Levée De Fonds Dilution OCEANE-BSA
BRIEF published on 05/05/2025 at 12:05, 1 year ago Neovacs raises 1.2 million euros in fundraising Biotechnology Fundraising Investment Dilution OCEANE-BSA
PRESS RELEASE published on 05/05/2025 at 12:00, 1 year ago Levée de fonds de 1,2 MEUR Néovacs annonce une levée de fonds de 1,2 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech Biotech Levée De Fonds Néovacs Kinoïde® Allergies
Published on 05/11/2026 at 19:55, 2 hours 15 minutes ago Lithium South Announces Pay Out of Common Shares and Closing of Plan of Arrangement
Published on 05/11/2026 at 19:30, 2 hours 40 minutes ago Taranis Adjusts Thor Exploration Program Due to Current Political and Regulatory Conditions in British Columbia
Published on 05/11/2026 at 14:30, 7 hours 40 minutes ago Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides
Published on 05/11/2026 at 14:00, 8 hours 10 minutes ago Unusual Machines Accelerates Domestic Battery Manufacturing by Signing a Merger Agreement to Acquire Upgrade Energy
Published on 05/11/2026 at 14:00, 8 hours 10 minutes ago New Horizon Aircraft Ltd. Announces Closing of $20 Million Offering of Common Shares
Published on 05/11/2026 at 22:05, 5 minutes ago Abivax annonce les résultats de son Assemblée Générale du 11 mai 2026
Published on 05/11/2026 at 22:05, 5 minutes ago Abivax Announces Results of its May 11, 2026 Annual General Meeting
Published on 05/11/2026 at 21:16, 53 minutes ago Original-Research: Intershop Communications (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 05/11/2026 at 20:42, 1 hour 27 minutes ago Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 20:40, 1 hour 30 minutes ago EQS-Adhoc: Grand City Properties S.A. proposes Dividend Payment combined with Dividend Policy Update
Published on 05/11/2026 at 19:02, 3 hours 7 minutes ago 260511 BENETEAU Transactions sur actions propres
Published on 05/11/2026 at 18:18, 3 hours 52 minutes ago Reporting on share buyback transactions carried out between May 4 and May 5, 2026
Published on 05/11/2026 at 18:18, 3 hours 52 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 4 et 5 mai 2026
Published on 05/11/2026 at 18:14, 3 hours 55 minutes ago Nombre total d'actions et droits de vote - avril 2026
Published on 05/11/2026 at 18:14, 3 hours 55 minutes ago Number of shares and voting rights - April 2026 (In French only)